Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $5.33 Million in Common Shares

Bitget2026/11/03 00:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gilead Sciences Chairman and CEO Daniel Patrick O'Day sold 30,881 common shares on Oct. 30 and Nov. 2, 2026.
The Oct. 30 sale covered 15,881 shares at $175.2456 per share.
Nov. 2 sales totaled 15,000 shares at reported prices ranging from $167.3999 to $171.0627 per share.
O'Day also exercised 15,881 non-qualified stock options at $72.34 per share on Oct. 30.
His directly owned common stock holdings stood at 551,683 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001638643-26-000038), on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $5.33 Million in Common Shares

You may also like

Crypto prices